FDA greenlights COVID-19 booster vaccine for some immunocompromised patients
August 13 2021, 08:00
The FDA authorized a COVID-19 booster shot for certain immunocompromised patients after evidence indicated a weak immune response following the initial two-dose series.
The FDA authorized a COVID-19 booster shot for certain immunocompromised patients after evidence indicated a weak immune response following the initial two-dose series.
Source:
FOX News